Avidity Partners, BlackRock, Pura Vida Investments, RA Capital Management and Sands Capital Management’s $220m venture financing deal with eXo Imaging was the medical devices industry’s biggest big data deal of Q3 2021 as big data deals worth $1bn were announced globally in the quarter, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 50.2% over the previous quarter and a drop of 66.9% when compared with the last four-quarter average of $3.08bn.
In terms of number of big data deals, the sector saw a drop of 16.52% with 24 deals in Q3 2021 against the average of 28.75 deals in the last four-quarters.
In value terms, Asia-Pacific led the activity with big data deals worth $404.24m.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
![](/wp-content/themes/goodlife-wp-B2B/assets/images/company-profile-unit.png)
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDatamedical devices industry big data deals in Q3 2021: Top deals
The top five medical devices industry big data deals accounted for 74.2% of the overall value during Q3 2021.
The combined value of the top five big data deals stood at $759.1m, against the overall value of $1bn recorded for the quarter.
The top five medical devices industry big data deals of Q3 2021 tracked by GlobalData were:
1) Avidity Partners,BlackRock,Pura Vida Investments,RA Capital Management and Sands Capital Management $220m venture financing deal with eXo Imaging
2) The $200m acquisition of Zebra Medical Vision by Nano-X Imaging
3) CCB Trust,Chinese Fund of Funds (FOF),Goldman Sachs Asset Management,Springhill Fund,TopoScend Capital and Zhongguancun M&A Fund $139.1m venture financing deal with Beijing Infervision Technology
4) The $100m venture financing of Pulse Medical Imaging Technology (Shanghai) by Boyu Capital Consultancy,GL Ventures,Goldman Sachs Group,Insight Capital,Koninklijke Philips and Linden Asset Management
5) Hibercell $100m acquisition deal with Genuity Science